TNFα and response of treatment-resistant adult-onset Still's disease to thalidomide
- 1 August 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9127) , 544-545
- https://doi.org/10.1016/s0140-6736(05)79252-7
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Thalidomide as an Anti-TNF-α Inhibitor: Implications for Clinical UseClinical Immunology and Immunopathology, 1996
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum LeprosumThe Journal of Infectious Diseases, 1993
- Thalidomide inhibits the replication of human immunodeficiency virus type 1.Proceedings of the National Academy of Sciences, 1993
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993